Combination Protocols: AOD-9604 can be combined with other metabolic support peptides or compounds, though careful consideration should be given to potential interactions
Patani N, Dunbier AK, Anderson H, et al
Key published studies include: Teichman et al., 2006 (JCEM): Dose-dependent GH and IGF-1 elevation with CJC-1295 DAC in healthy adults Raun et al., 1998 (Eur J Endocrinol): Ipamorelin demonstrated selective GH release without cortisol/prolactin elevation Johansen et al., 1999: Phase I/II Ipamorelin trial showed dose-response relationship with no significant adverse effects Bowers et al., 2004: Foundational research on GHRH/GHRP synergistic GH release mechanisms Neither CJC-1295 nor Ipamorelin has completed Phase 3 clinical trials
People most at risk of deficiency include older adults, vegans, and those with specific medical conditions or taking certain medications
However, they are not enough on their own to fade stubborn pigmentation or dark spots, which usually require leave-on treatments and consistent sun protection
If you experience significant side effects during this phase, stay at the current dose for an additional week before increasing
